Applying Retinal Vascular Structures Characteristics Coupling with Cortical Visual System in Alzheimer’s Disease Spectrum Patients

Cortical visual system dysfunction is closely related to the progression of Alzheimer’s Disease (AD), while retinal vascular structures play an important role in the integrity of the function of the visual network and are a potential biomarker of AD. This study explored the association between the cortical visual system and retinal vascular structures in AD-spectrum patients, and it established a screening tool to detect preclinical AD based on these parameters identified in a retinal examination. A total of 42 subjects were enrolled and were distributed into two groups: 22 patients with cognitive impairment and 20 healthy controls. All participants underwent neuropsychological tests, optical coherence tomography angiography and resting-state fMRI imaging. Seed-based functional connectivity analysis was used to construct the cortical visual network. The association of functional connectivity of the cortical visual system and retinal vascular structures was further explored in these subjects. This study found that the cognitive impairment group displayed prominently decreased functional connectivity of the cortical visual system mainly involving the right inferior temporal gyrus, left supramarginal gyrus and right postcentral gyrus. Meanwhile, we observed that retinal vascular structure characteristics deteriorated with the decline in functional connectivity in the cortical visual system. Our study provided novel insights into the aberrant cortical visual system in patients with cognitive impairment that strongly emphasized the critical role of retinal vascular structure characteristics, which could be used as potential biomarkers for diagnosing and monitoring the progression of AD.

[1]  O. Sporns,et al.  The human connectome in Alzheimer disease — relationship to biomarkers and genetics , 2021, Nature Reviews Neurology.

[2]  Jae Seung Kim,et al.  Early Impairment in the Ventral Visual Pathway Can Predict Conversion to Dementia in Patients With Amyloid-negative Amnestic Mild Cognitive Impairment , 2021, Alzheimer disease and associated disorders.

[3]  P. Wong,et al.  Brain metabolism in tau and amyloid mouse models of Alzheimer's disease: An MRI study , 2021, NMR in biomedicine.

[4]  L. Schneider,et al.  Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group , 2021, The Lancet Neurology.

[5]  D. Y. Lee,et al.  Association of Retinal Changes With Alzheimer Disease Neuroimaging Biomarkers in Cognitively Normal Individuals. , 2021, JAMA ophthalmology.

[6]  Rena Li,et al.  Relationship Between Alzheimer's Disease and Retinal Choroidal Thickness: A Cross-Sectional Study. , 2021, Journal of Alzheimer's disease : JAD.

[7]  M. Barbancho,et al.  Correlation between retinal nerve fibre layer thickness and white matter lesions in Alzheimer's disease , 2021, International journal of geriatric psychiatry.

[8]  Jeremiah K. H. Lim,et al.  Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances , 2020, Progress in Retinal and Eye Research.

[9]  Justis P. Ehlers,et al.  Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases , 2020, PloS one.

[10]  Fidelis Chibhabha,et al.  Retinal involvement in Alzheimer's disease (AD): evidence and current progress on the non-invasive diagnosis and monitoring of AD-related pathology using the eye , 2020, Reviews in the neurosciences.

[11]  K. Mcmahon,et al.  Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis , 2020, Journal of Neurology.

[12]  Chunbo Li,et al.  Retinal nerve fiber layer thickness is associated with hippocampus and lingual gyrus volumes in nondemented older adults , 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[13]  G. Van Stavern Current opinion neurology: visual pathway biomarkers in Alzheimer's disease. , 2019, Current opinion in neurology.

[14]  J. Petrella,et al.  Correlation of OCTA and Volumetric MRI in Mild Cognitive Impairment and Alzheimer's Disease. , 2019, Ophthalmic surgery, lasers & imaging retina.

[15]  S. Salomone,et al.  Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas. , 2019, Pharmacology & therapeutics.

[16]  Sashank Prasad,et al.  Higher Cortical Visual Disorders. , 2019, Continuum.

[17]  M. Castelo‐Branco,et al.  Interplay Between Macular Retinal Changes and White Matter Integrity in Early Alzheimer’s Disease , 2019, Journal of Alzheimer's disease : JAD.

[18]  Stefano Tamburin,et al.  Comparison between physical and cognitive treatment in patients with MIC and Alzheimer’s disease , 2019, Aging.

[19]  Nick C Fox,et al.  Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease , 2018, NeuroImage: Clinical.

[20]  Shahina Pardhan,et al.  How does aging influence object-location and name-location binding during a visual short-term memory task? , 2020, Aging & mental health.

[21]  J. Lauermann,et al.  Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography. , 2018, Journal of Alzheimer's disease : JAD.

[22]  J. Dartigues,et al.  Association of Retinal Nerve Fiber Layer Thickness With Brain Alterations in the Visual and Limbic Networks in Elderly Adults Without Dementia , 2018, JAMA network open.

[23]  N. Kung,et al.  Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings , 2018, JAMA ophthalmology.

[24]  R. González-Reyes,et al.  Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview , 2018, Neural plasticity.

[25]  Antonino Cattaneo,et al.  The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model , 2018, Neurobiology of Aging.

[26]  Justis P. Ehlers,et al.  Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease , 2018, Investigative ophthalmology & visual science.

[27]  Olivier Piguet,et al.  Can visuospatial measures improve the diagnosis of Alzheimer's disease? , 2017, Alzheimer's & dementia.

[28]  P. Scheltens,et al.  Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer's disease and controls , 2017, Alzheimer's & dementia.

[29]  Giovanni Gregori,et al.  Altered Macular Microvasculature in Mild Cognitive Impairment and Alzheimer Disease , 2017, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[30]  Keith L Black,et al.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.

[31]  Mehmet Bulut,et al.  Evaluation of optical coherence tomography angiographic findings in Alzheimer’s type dementia , 2017, British Journal of Ophthalmology.

[32]  David C. Plaut,et al.  ‘What’ Is Happening in the Dorsal Visual Pathway , 2016, Trends in Cognitive Sciences.

[33]  K. Black,et al.  Ocular indicators of Alzheimer’s: exploring disease in the retina , 2016, Acta Neuropathologica.

[34]  Yufeng Zang,et al.  DPABI: Data Processing & Analysis for (Resting-State) Brain Imaging , 2016, Neuroinformatics.

[35]  C. F. Costa,et al.  Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimerʼs Disease , 2016, PloS one.

[36]  Chelsea C. Hays,et al.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease , 2016, Cellular and Molecular Neurobiology.

[37]  Julie C. Stout,et al.  The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease , 2015, Neuropsychologia.

[38]  Elena Garcia-Martin,et al.  Visual function and retinal nerve fibre layer degeneration in patients with Alzheimer disease: correlations with severity of dementia , 2015, Acta ophthalmologica.

[39]  T. Wong,et al.  Retinal neurodegeneration on optical coherence tomography and cerebral atrophy , 2015, Neuroscience Letters.

[40]  S. Salomone,et al.  MicroRNA target prediction in glaucoma. , 2015, Progress in brain research.

[41]  Radouil Tzekov,et al.  Vision function abnormalities in Alzheimer disease. , 2014, Survey of ophthalmology.

[42]  A. Saykin,et al.  Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection. , 2013, Annual review of clinical psychology.

[43]  Cindee M. Madison,et al.  Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. , 2013, Brain : a journal of neurology.

[44]  R. Akinyemi,et al.  Does vascular pathology contribute to Alzheimer changes? , 2012, Journal of the Neurological Sciences.

[45]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[46]  F. Schmitt,et al.  Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[47]  Joseph T. Devlin,et al.  Supramarginal gyrus involvement in visual word recognition , 2009, Cortex.

[48]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[49]  Edward H Herskovits,et al.  Neural regions essential for reading and spelling of words and pseudowords , 2007, Annals of neurology.

[50]  Y. Iwamura Hierarchical somatosensory processing , 1998, Current Opinion in Neurobiology.

[51]  A. Damasio,et al.  The anatomic basis of pure alexia , 1983, Neurology.